NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-69 Cr | ₹-136 Cr | ₹38 Cr | ₹-114 Cr | ₹-5.48 Cr |
What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-69 Cr |
Mar2023 | ₹-136 Cr |
Mar2022 | ₹38 Cr |
Mar2021 | ₹-114 Cr |
Mar2020 | ₹-5.48 Cr |
How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-69 Cr | Negative | |
Mar2023 | ₹-136 Cr | Negative | |
Mar2022 | ₹38 Cr | Positive | |
Mar2021 | ₹-114 Cr | Negative | |
Mar2020 | ₹-5.48 Cr | - |
Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹15,407.2 Cr | -8% | 6.8% | 72.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹439,126.0 Cr | 1.4% | 4.1% | 18.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,568.0 Cr | -2.1% | 4.2% | 59.1% | Stock Analytics | |
CIPLA | ₹125,156.0 Cr | -0.1% | 5% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,176.0 Cr | -0.3% | 3% | 23.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,716.1 Cr | -1.5% | 1.7% | -5.4% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -8% |
6.8% |
72.3% |
SENSEX | 0.2% |
2.9% |
8.7% |
You may also like the below Video Courses